DOYLE JOHN BRENDAN (Chief Financial Officer) received a stock award from COGNITION THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/22/2025ACC: 0001104659-25-123721
Officer· Chief Financial Officer
Since Feb 2026
+20.64K
Net shares
Net buyer
$14.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
30K acquired · 9.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
7.1%
12/18/2025
425.35K→455.35K
Common Stock
Direct
Shares
−9.36K
Price / share
$1.50
Trade value
$14.04K
% of position
2.1%
12/18/2025
455.35K→445.99K
Total
Net shares
+20.64K
Net value
-$14.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | A · Award | +30K | — | — | 7.1% | 425.35K | 455.35K |
| Common Stock Direct | 12/18/2025 | F · Tax Withholding | −9.36K | $1.50 | $14.04K | 2.1% | 455.35K | 445.99K |
| Total | +20.64K | -$14.04K | ||||||
Derivative Transactions0
No derivative transactions reported